GLP-1s' Effects on Cancer Risk May Be Influenced by Diabetes Severity

Summary
(MedPage Today) -- Diabetic patients treated with GLP-1 receptor agonists had a lower cancer risk versus insulin and sulfonylureas but not other diabetes medications, although the benefits varied by diabetes severity, a large cohort analysis with...
Description from Medpagetoday.
Who is covering this
-
GLP-1s' Effects on Cancer Risk May Be Influenced by Diabetes Severity
(MedPage Today) -- Diabetic patients treated with GLP-1 receptor agonists had a lower cancer risk versus insulin and sulfonylureas but not other diabetes medications, although the benefits varied by diabetes severity, a large cohort analysis with...
Comments
Comments need JavaScript.